Cargando…

Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics

BACKGROUND: The validity of observational studies and their meta-analyses is contested. Here, we aimed to appraise thousands of meta-analyses of observational studies using a pre-specified set of quantitative criteria that assess the significance, amount, consistency, and bias of the evidence. We al...

Descripción completa

Detalles Bibliográficos
Autores principales: Janiaud, Perrine, Agarwal, Arnav, Tzoulaki, Ioanna, Theodoratou, Evropi, Tsilidis, Konstantinos K., Evangelou, Evangelos, Ioannidis, John P. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259334/
https://www.ncbi.nlm.nih.gov/pubmed/34225716
http://dx.doi.org/10.1186/s12916-021-02020-6
_version_ 1783718650541244416
author Janiaud, Perrine
Agarwal, Arnav
Tzoulaki, Ioanna
Theodoratou, Evropi
Tsilidis, Konstantinos K.
Evangelou, Evangelos
Ioannidis, John P. A.
author_facet Janiaud, Perrine
Agarwal, Arnav
Tzoulaki, Ioanna
Theodoratou, Evropi
Tsilidis, Konstantinos K.
Evangelou, Evangelos
Ioannidis, John P. A.
author_sort Janiaud, Perrine
collection PubMed
description BACKGROUND: The validity of observational studies and their meta-analyses is contested. Here, we aimed to appraise thousands of meta-analyses of observational studies using a pre-specified set of quantitative criteria that assess the significance, amount, consistency, and bias of the evidence. We also aimed to compare results from meta-analyses of observational studies against meta-analyses of randomized controlled trials (RCTs) and Mendelian randomization (MR) studies. METHODS: We retrieved from PubMed (last update, November 19, 2020) umbrella reviews including meta-analyses of observational studies assessing putative risk or protective factors, regardless of the nature of the exposure and health outcome. We extracted information on 7 quantitative criteria that reflect the level of statistical support, the amount of data, the consistency across different studies, and hints pointing to potential bias. These criteria were level of statistical significance (pre-categorized according to 10(−6), 0.001, and 0.05 p-value thresholds), sample size, statistical significance for the largest study, 95% prediction intervals, between-study heterogeneity, and the results of tests for small study effects and for excess significance. RESULTS: 3744 associations (in 57 umbrella reviews) assessed by a median number of 7 (interquartile range 4 to 11) observational studies were eligible. Most associations were statistically significant at P < 0.05 (61.1%, 2289/3744). Only 2.6% of associations had P < 10(−6), ≥1000 cases (or ≥20,000 participants for continuous factors), P < 0.05 in the largest study, 95% prediction interval excluding the null, and no large between-study heterogeneity, small study effects, or excess significance. Across the 57 topics, large heterogeneity was observed in the proportion of associations fulfilling various quantitative criteria. The quantitative criteria were mostly independent from one another. Across 62 associations assessed in both RCTs and in observational studies, 37.1% had effect estimates in opposite directions and 43.5% had effect estimates differing beyond chance in the two designs. Across 94 comparisons assessed in both MR and observational studies, such discrepancies occurred in 30.8% and 54.7%, respectively. CONCLUSIONS: Acknowledging that no gold-standard exists to judge whether an observational association is genuine, statistically significant results are common in observational studies, but they are rarely convincing or corroborated by randomized evidence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02020-6.
format Online
Article
Text
id pubmed-8259334
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82593342021-07-06 Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics Janiaud, Perrine Agarwal, Arnav Tzoulaki, Ioanna Theodoratou, Evropi Tsilidis, Konstantinos K. Evangelou, Evangelos Ioannidis, John P. A. BMC Med Research Article BACKGROUND: The validity of observational studies and their meta-analyses is contested. Here, we aimed to appraise thousands of meta-analyses of observational studies using a pre-specified set of quantitative criteria that assess the significance, amount, consistency, and bias of the evidence. We also aimed to compare results from meta-analyses of observational studies against meta-analyses of randomized controlled trials (RCTs) and Mendelian randomization (MR) studies. METHODS: We retrieved from PubMed (last update, November 19, 2020) umbrella reviews including meta-analyses of observational studies assessing putative risk or protective factors, regardless of the nature of the exposure and health outcome. We extracted information on 7 quantitative criteria that reflect the level of statistical support, the amount of data, the consistency across different studies, and hints pointing to potential bias. These criteria were level of statistical significance (pre-categorized according to 10(−6), 0.001, and 0.05 p-value thresholds), sample size, statistical significance for the largest study, 95% prediction intervals, between-study heterogeneity, and the results of tests for small study effects and for excess significance. RESULTS: 3744 associations (in 57 umbrella reviews) assessed by a median number of 7 (interquartile range 4 to 11) observational studies were eligible. Most associations were statistically significant at P < 0.05 (61.1%, 2289/3744). Only 2.6% of associations had P < 10(−6), ≥1000 cases (or ≥20,000 participants for continuous factors), P < 0.05 in the largest study, 95% prediction interval excluding the null, and no large between-study heterogeneity, small study effects, or excess significance. Across the 57 topics, large heterogeneity was observed in the proportion of associations fulfilling various quantitative criteria. The quantitative criteria were mostly independent from one another. Across 62 associations assessed in both RCTs and in observational studies, 37.1% had effect estimates in opposite directions and 43.5% had effect estimates differing beyond chance in the two designs. Across 94 comparisons assessed in both MR and observational studies, such discrepancies occurred in 30.8% and 54.7%, respectively. CONCLUSIONS: Acknowledging that no gold-standard exists to judge whether an observational association is genuine, statistically significant results are common in observational studies, but they are rarely convincing or corroborated by randomized evidence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02020-6. BioMed Central 2021-07-06 /pmc/articles/PMC8259334/ /pubmed/34225716 http://dx.doi.org/10.1186/s12916-021-02020-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Janiaud, Perrine
Agarwal, Arnav
Tzoulaki, Ioanna
Theodoratou, Evropi
Tsilidis, Konstantinos K.
Evangelou, Evangelos
Ioannidis, John P. A.
Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
title Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
title_full Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
title_fullStr Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
title_full_unstemmed Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
title_short Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
title_sort validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259334/
https://www.ncbi.nlm.nih.gov/pubmed/34225716
http://dx.doi.org/10.1186/s12916-021-02020-6
work_keys_str_mv AT janiaudperrine validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics
AT agarwalarnav validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics
AT tzoulakiioanna validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics
AT theodoratouevropi validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics
AT tsilidiskonstantinosk validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics
AT evangelouevangelos validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics
AT ioannidisjohnpa validityofobservationalevidenceonputativeriskandprotectivefactorsappraisalof3744metaanalyseson57topics